Worth reading
69In focus
Scored from 2 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
220000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Substantial exercise of the 7th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
発行・処分する株式数
220,000 new shares (80,000 shares on 17 August 2026, 60,000 shares on 18 August, and 80,000 shares on 19 August)
Intended allottee
GP上場企業出資投資事業有限責任組合 (the allottee of the already-issued stock acquisition rights)
Terms of the stock acquisition rights
Exercise price
¥387 (17 August), ¥365 (18 August), and ¥353 (19 August). Details of the adjustment provisions and the adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Equivalent to 20,060 rights issued in total (the 2,200 rights exercised represented 10.97% of the total issued). Unexercised rights as of the previous disclosure: 11,626; unexercised rights as of the current date: 9,426
Most recent equity financing
Timing 15 June 2026 / Type Issuance of the Seventh Series of Stock Acquisition Rights through a third-party allotment (with exercise price adjustment provisions) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Substantial exercise of the 7th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 220,000 new shares (80,000 shares on 17 August 2026, 60,000 shares on 18 August, and 80,000 shares on 19 August) |
| Intended allottee | GP上場企業出資投資事業有限責任組合 (the allottee of the already-issued stock acquisition rights) |
| Exercise price | ¥387 (17 August), ¥365 (18 August), and ¥353 (19 August). Details of the adjustment provisions and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Equivalent to 20,060 rights issued in total (the 2,200 rights exercised represented 10.97% of the total issued). Unexercised rights as of the previous disclosure: 11,626; unexercised rights as of the current date: 9,426 |
| Most recent equity financing | Timing 15 June 2026 / Type Issuance of the Seventh Series of Stock Acquisition Rights through a third-party allotment (with exercise price adjustment provisions) / Amount Not disclosed |
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company has not stated the reason for the bulk exercise.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.